​

Traws Pharma Ownership | Who Owns Traws Pharma?

OverviewChartTranscripts

Traws Pharma Ownership Summary

Traws Pharma is owned by 21.71% institutional investors, 14.86% insiders, and 63.44% retail investors. Orbimed advisors is the largest institutional shareholder, holding 10.40% of TRAW shares.

TRAW Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTraws Pharma21.71%14.86%63.44%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 307.00%11.11%-218.12%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Orbimed advisors605.53K10.40%$896.19K
Adage capital partners gp330.00K5.67%$488.40K
Vestal point capital, lp149.80K2.57%$221.70K
Alyeska investment group52.63K0.90%$77.89K
Ikarian capital28.49K0.49%$42.17K
Two sigma securities17.17K0.29%$25.41K
Blackrock funding, inc. /de9.96K0.17%$14.73K
Raymond james financial102.000.00%$151.00
Vermillion & white wealth management group96.000.00%$142.00
Boothbay fund management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Orbimed advisors605.53K0.02%$896.19K
Vestal point capital, lp149.80K0.01%$221.70K
Ikarian capital28.49K0.01%$42.17K
Two sigma securities17.17K0.00%$25.41K
Adage capital partners gp330.00K0.00%$488.40K
Alyeska investment group52.63K0.00%$77.89K
Vermillion & white wealth management group96.000.00%$142.00
Boothbay fund management---
Blackrock funding, inc. /de9.96K-$14.73K
Raymond james financial102.00-$151.00

Top Buyers

HolderShares% AssetsChange
Two sigma securities17.17K0.00%17.17K
Raymond james financial102.00-102.00
Adage capital partners gp330.00K0.00%-
Vermillion & white wealth management group96.000.00%-
Ikarian capital28.49K0.01%-

Top Sellers

HolderShares% AssetsChange
Boothbay fund management---33.30K
Vestal point capital, lp149.80K0.01%-25.20K
Vermillion & white wealth management group96.000.00%-
Blackrock funding, inc. /de9.96K--
Alyeska investment group52.63K0.00%-

New Positions

HolderShares% AssetsChangeValue
Two sigma securities17.17K0.00%17.17K$25.41K
Raymond james financial102.00-102.00$151.00

Sold Out

HolderChange
Boothbay fund management-33.30K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202519-1,263,487-27.06%2146.34%6-50.00%525.00%
Mar 31, 2025195.56%1,732,32748.01%632.01%12-4100.00%
Dec 31, 20241880.00%1,170,40681.08%470.91%1220.00%2-
Sep 30, 202410-646,356-2-10---

Recent Insider Transactions

DateNameRoleActivityValue
Dec 29, 2024ORBIMED ADVISORS LLC-Buy$963.48
Dec 29, 2024ORBIMED ADVISORS LLC-Buy$1.29M
Dec 29, 2024CAUTREELS WERNER Chief Executive OfficerBuy$963.48
Dec 29, 2024CAUTREELS WERNER Chief Executive OfficerBuy$1.29M
Dec 29, 2024TPAV, LLC-Buy$963.48

Insider Transactions Trends

DateBuySell
2025 Q1--
2024 Q48-
2024 Q3--
2024 Q2--

TRAW Ownership FAQ

Who Owns Traws Pharma?

Traws Pharma shareholders are primarily institutional investors at 21.71%, followed by 14.86% insiders and 63.43% retail investors. The average institutional ownership in Traws Pharma's industry, Biotech Stocks , is 307.00%, which Traws Pharma falls below.

Who owns the most shares of Traws Pharma?

Traws Pharma’s largest shareholders are Orbimed advisors (605.53K shares, 10.40%), Adage capital partners gp (330K shares, 5.67%), and Vestal point capital, lp (149.8K shares, 2.57%). Together, they hold 18.65% of Traws Pharma’s total shares outstanding.

Does Blackrock own Traws Pharma?

BlackRock is not among the top 10 institutional shareholders of Traws Pharma.

Who is Traws Pharma’s biggest shareholder by percentage of total assets invested?

Orbimed advisors is Traws Pharma’s biggest shareholder by percentage of total assets invested, with 0.02% of its assets in 605.53K Traws Pharma shares, valued at 896.19K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools